Todd Ponzio

Todd Ponzio serves as a key procurement lead at the Naval Medical Research Center, supporting the Department of the Navy’s mission to enhance force health protection through advanced biomedical research. He manages the acquisition of research and development services focused on field-deployable diagnostics, infectious disease detection systems, and laboratory analytical tools designed for austere operational environments. His portfolio centers on technical contracts that enable rapid innovation in military medicine, ensuring that emerging pathogen surveillance and precision monitoring technologies meet expeditionary operational requirements. Ponzio plays a critical role in translating scientific priorities into actionable procurement strategies aligned with DoD research objectives. His primary contractor relationship is with REES SCIENTIFIC CORPORATION, a trusted partner in the development of specialized diagnostic and biomedical research solutions. Ponzio consistently engages this vendor for complex, high-precision R&D services requiring expertise in molecular diagnostics, biosensor integration, and field-adaptable lab systems. His contracting pattern reflects a preference for established technical partners with proven capability in delivering mission-critical scientific instrumentation and analytical platforms, indicating a focus on reliability, compliance, and technical fidelity over broad competition. Ponzio’s procurement activity shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a mission-driven emphasis on technical merit and capability over socioeconomic preferences, consistent with the highly specialized nature of the research being procured. While small business participation is not formally prioritized, his acquisitions remain accessible to all qualified vendors capable of meeting stringent technical specifications. His acquisitions are exclusively classified under NAICS 541712—Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). He procures advanced laboratory equipment, diagnostic assay development, pathogen detection platforms, and data analytics systems tailored for military medical research. His expertise lies in the technical domain of infectious disease surveillance, point-of-care diagnostics, and deployable biomedical instrumentation for naval and marine forces.